KrystinaLWoodsMD

PubMed

• 21 citations
  Nested Case-Control Study of the Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae
  Masayuki Nigo, Catalina Salinas Cevallos, Krystina L. Woods, Vicente Maco Flores, Gweneth Francis
  Antimicrobial Agents and Chemotherapy. 2013-11-01
• 5 citations
  Community-Associated Escherichia coli Harboring CTX-M β-Lactamases from Urine Cultures from Pediatric Patients
  Krystina L. Woods, James R. Johnson, Sofia Padkowsky, Noriel Mariano, Rita Colon-Urban
  Antimicrobial Agents and Chemotherapy. 2012-01-17
• 2 citations
  What Is the Prevalence of Measles Immunity among Pregnant Women
  Melissa Chu Lam, Emily Schmidt-Beuchat, Emma T. Geduldig, Lois Brustman, Katie Hyewon Choi
  American Journal of Perinatology. 2021-01-01

Abstracts/Posters

• Mandatory Pre-Authorization or “Hard Stop Order” to Decrease Inappropriate Testing for Clostridium difficile Infection. A Testing Stewardship at 2 Hospitals
  A Gabasan, BA Smith, KL Woods, M Ordoveza, O Dzenkevych, D Schwing, B Camins, EM Sordillo, Association for Professionals in Infection Control and Epidemiology (APIC) Conference, Philadelphia, PA, 6/13/2019
• Halting Transmission of a Methicillin-Sensitive Staphylococcus aureus Strain in a Level 3 Neonatal Intensive Care Unit
  Woods KL, Altman DR, Gabasan A, Schwing D, Smith BA, Beckford C, Hamula C, Oussenko I, Smith M, Sullivan M, van Bakel H, Eiland L, Camins B, Sordillo EM, Society for Healthcare Epidemiology of America (SHEA) Conference, Boston, MA, 4/24/2019
• Outbreak of a Late-Onset Group B Streptococcus Cluster due to Probable Horizontal Transmission in a Level 3 Neonatal Intensive Care Unit
  Oikonomou K, Gabasan A, Woods KL, Sordillo EM, the ID Society of America (IDSA) ID Week, San Francisco, CA, 10/3/2018
• Investigating a Human Parainfluenza Virus Type-3 Outbreak in a Level 3 Neonatal Intensive Care Unit
  Williams M, Gabasan A, Woods KL, Society for Healthcare Epidemiology of America (SHEA) Conference, Portland, OR, 4/20/2018
• Piperacillin/tazobactam- and Cefepime-Based Therapy in Hospitalized Patients and the Risk of Subsequent Isolation of Multidrug-Resistant Organisms (MDRO)
  Woods K, Jodlowski T, Revuelta M, Mildvan D, Perlman D, Ruhe J, ID Society of America ID Week Conference, San Francisco, CA, USA, 10/4/2013
• Rates of and risk factors for the emergence of tigecycline resistance among multidrug-resistant Klebsiella pneumoniae isolates.
  Nigo M, Salinas Cevallos C, Woods K, Maco Flores V, Francis G, Mildvan D, Waldron M, Gomez T, Koshy S, Ruhe J, European Congress of Clinical Microbiology & Infectious Diseases, London, England, 4/2/2012
• Join now to see all